Skip to main navigation Skip to search Skip to main content

CTU: A Phase I Study to Evaluate the Safety, Pharmacokinetics and Anti-tumor Activity of SSGJ-709 in Patients with Advanced Malignant Tumors

  • Parsonson, Andrew (Primary Chief Investigator)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • Armstrong, Emilia (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)
  • Chik, Jenny (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleSSGJ-709-101
StatusFinished
Effective start/end date23/04/2523/04/26